Cargando…
Development of dual inhibitors targeting DprE1 and AHAS for treatment of Mycobacterium tuberculosis infection
Autores principales: | Chikhale, Rupesh V, Pant, Amit M, Menghani, Sunil S, Khedekar, Pramod B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080246/ http://dx.doi.org/10.1186/1471-2334-14-S3-E24 |
Ejemplares similares
-
LEDGF/p75 IN interaction inhibitors: in silico studies of an old target with novel approach
por: Pant, Amit M, et al.
Publicado: (2014) -
Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies
por: Bhutani, Isha, et al.
Publicado: (2015) -
Smallest Organism; Highest Threat
por: Pant, Amit, et al.
Publicado: (2012) -
Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus
In Vitro
por: Sarathy, Jickky Palmae, et al.
Publicado: (2022) -
Use of multi-primer / multi-gene PCR method for the detection of Mycobacterium tuberculosis among female genital tuberculosis patients in India
por: Bhanothu, Venkanna, et al.
Publicado: (2014)